share_log

Aprea Therapeutics on Wednesday Received FDA Orphan Drug Designation for eprenetapopt for Treatment of Acute Myeloid Leukemia

Aprea Therapeutics on Wednesday Received FDA Orphan Drug Designation for eprenetapopt for Treatment of Acute Myeloid Leukemia

Aprea治疗公司周三获得FDA用于治疗急性髓系白血病的Eprenetapopt孤儿药物名称
Benzinga Real-time News ·  2021/04/08 05:02

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=797420

Https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=797420

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发